1. Home
  2. FBIO vs SCOR Comparison

FBIO vs SCOR Comparison

Compare FBIO & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortress Biotech Inc.

FBIO

Fortress Biotech Inc.

HOLD

Current Price

$2.67

Market Cap

111.0M

Sector

Health Care

ML Signal

HOLD

Logo comScore Inc.

SCOR

comScore Inc.

HOLD

Current Price

$7.20

Market Cap

101.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBIO
SCOR
Founded
2006
1999
Country
United States
United States
Employees
78
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
111.0M
101.6M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
FBIO
SCOR
Price
$2.67
$7.20
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
694.0K
6.5K
Earning Date
05-15-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
127.37
EPS
N/A
N/A
Revenue
N/A
$403,549,000.00
Revenue This Year
$55.22
$2.75
Revenue Next Year
$40.55
$7.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.02
52 Week Low
$1.83
$6.10
52 Week High
$4.53
$10.18

Technical Indicators

Market Signals
Indicator
FBIO
SCOR
Relative Strength Index (RSI) 37.51 52.15
Support Level $2.31 $6.41
Resistance Level $2.94 $7.82
Average True Range (ATR) 0.20 0.44
MACD -0.10 0.01
Stochastic Oscillator 14.56 64.49

Price Performance

Historical Comparison
FBIO
SCOR

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

About SCOR comScore Inc.

comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.

Share on Social Networks: